Please login to the form below

Not currently logged in
Email:
Password:

ABPI

This page shows the latest ABPI news and features for those working in and with pharma, biotech and healthcare.

Industry pleads for compromise after Brexit defeat

Industry pleads for compromise after Brexit defeat

The Association of the British Pharmaceutical Industry (ABPI) chief executive Mike Thompson said that no-deal would be “extremely challenging” and raises the risk that access to medicines may be disrupted

Latest news

More from news
Approximately 87 fully matching, plus 473 partially matching documents found.

Latest Intelligence

  • The UK’s new five-year pricing agreement The UK’s new five-year pricing agreement

    Industry leaders who have voiced their support for the deal include Novartis’ UK country president Haseeb Ahmad and EMIG’s chairman Leslie Galloway, who says the ABPI’s negotiating team had ... NHS England, with input from NICE and ABPI, committed

  • Brexit: can pharma 'take back control' of the narrative? Brexit: can pharma 'take back control' of the narrative?

    For this reason, as the clock ticks down, the sector urgently needs greater clarification across the five broad areas that have been identified by the ABPI and BIA: access to ... Nonetheless despite this, the ABPI has long-highlighted the need to bridge

  • In conversation with Pfizer’s Erik Nordkamp In conversation with Pfizer’s Erik Nordkamp

    Pfizer’s UK managing director and newly appointed ABPI President talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe. " />.

  • Joint working that works Joint working that works

    The ABPI and Department of Health defined how companies and the NHS can pool skills, experience and resources to plan and deliver patient-centred projects. ... Our experts reflected that the healthcare landscape has evolved since Moving Beyond

  • The case for a second Brexit referendum: “We need the informed consent of the people” The case for a second Brexit referendum: “We need the informed consent of the people”

    There is no doubt that the amendment was seen in the UK pharma industry as a huge vote of support – even if trade organisation the ABPI is very careful about speaking

More from intelligence
Approximately 7 fully matching, plus 41 partially matching documents found.

Latest appointments

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    His career history has seen him work in private equity and venture capital and he has been president of the ABPI.

  • Professor Carole Longson moves from NICE to the ABPI Professor Carole Longson moves from NICE to the ABPI

    Longson brings research, academic and pharmaceutical industry experience to the ABPI, including seven years as a research lead at GlaxoSmithKline. ... experience, expertise and network in both industry and academia will enable the ABPI to work with our

  • HCA appoints Mike Dixon as its new CEO HCA appoints Mike Dixon as its new CEO

    Commenting on behalf of the HCA Executive Committee, ABPI executive director of communications Aileen Thompson said: “We are really pleased that Mike has decided to lead the HCA at this critical

  • AZ's Lisa Anson elected president of ABPI AZ's Lisa Anson elected president of ABPI

    year. Anson joined the ABPI board in 2012 and has since overseen a number of schemes for the association, including the implementation of the Pharmaceutical Pricing Regulation Scheme. ... Speaking on behalf of the board and all staff at the ABPI, we very

  • ABPI appoints Mike Thompson as chief executive ABPI appoints Mike Thompson as chief executive

    He replaces acting chief executive officer Alison Clough. The Association of the British Pharmaceutical Industry (ABPI) has named Mike Thompson as its new chief executive, who will replace Alison Clough on ... and his strategic capabilities will be huge

More from appointments
Approximately 21 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 21 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics